Company Information

  

Address: 305 COLLEGE ROAD EAST  
City: PRINCETON, 
State: NJ 
Zip Code: 08540 
Telephone: 732 545 1590 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

Advaxis, Inc. ("Advaxis" or the "Company") is a clinical stage biotechnology company focused on the discovery, development and commercialization of proprietary Lm-LLO cancer immunotherapies. These immunotherapies are based on a platform technology that utilizes live attenuated Listeria monocytogenes ("Lm" or "Listeria" or "Lm TechnologyTM") bioengineered to secrete antigen/adjuvant fusion proteins. These Lm-LLO strains are believed to be a significant advancement in immunotherapy as they integrate multiple functions into a single immunotherapy as they access and direct antigen presenting cells to stimulate anti-tumor T-cell immunity, stimulate and activate the immune system with the equivalent of multiple adjuvants, and simultaneously reduce tumor protection in the tumor microenvironment to enable the T-cells to eliminate tumors.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
07/2017-2.30NAN/E
04/2017-1.97NAN/E
01/2017-1.92NAN/E
10/2016-2.08NAN/E
07/2016-1.90NAN/E
04/2016-1.85NAN/E
01/2016-1.94NAN/E
10/2015-1.68NAN/E

Key Financial Ratios and Statistics

FYE: 10/31

Profitability 2016 Leverage 2016
Net Inc/Comm Equity-0.22Total Liab/Total Assets0.29
Net Inc/Total Assets-0.44Total Liab/Inv Cap0.35
Net Inc/Inv Cap-0.52Total Liab/Comm Equity0.15
Pretax Inc/Net Sales-19.05Interest Coverage RatioNA
Net Inc/Net Sales-18.41Curr Debt/Equity0.00
Cash Flow/Net Sales-2.27LTD/Equity0.00
SG&A/NetSales7.94Total Debt/Equity0.00
Asset Utilization   Liquidity  
Net Receivables Turnover1.82Quick Ratio5.77
Inventory TurnoverNACurrent Ratio5.77
Inventory Day SalesNANet Rec/Curr Assets0.02
Net Sales/Work Cap0.03Inv/Curr AssetsNA
Net Sales/PP&E0.91  

Income Statement (Millions)

  7/31/2017 4/30/2017 1/31/2017 10/31/2016
Total Revenues(Net Sales) 3.05 3.43 3.79 3.74
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 18.06 7.78 7.33 11.32
Operating Income -32.81 -20.66 -17.19 -24.38
Interest Exp NA NA NA NA
Pretax Income -32.63 -20.47 -17.03 -24.25
Other Income 0.18 0.20 0.15 0.13
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -32.63 -20.47 -17.08 -21.70

Balance Sheet (Millions)

Assets 7/31/2017 4/30/2017 1/31/2017 10/31/2016
Cash & Short Term Investments 89.41 115.32 136.86 152.09
Receivables - Total 1.73 4.73 0.18 2.63
Inventories - Total NA NA NA NA
Total Current Assets 97.88 126.22 142.19 159.88
Net Property, Plant & Equipment 7.34 6.57 5.24 4.39
Total Assets 110.72 137.89 152.19 169.04
Liabilities        
Accounts Payable 9.14 15.79 11.21 12.63
Debt in Current Liabilities 0.04 0.04 0.04 0.04
Total Current Liabilities 21.29 29.88 25.31 27.71
Long-Term Debt 0.29 0.31 0.32 0.33
Total Liabilities 36.36 46.02 44.83 49.74
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 0.04 0.04 0.04 0.04
Retained Earnings -277.88 -245.26 -224.79 -207.71
Treasury Stock 0.00 0.00 0.00 -0.13
Total Stockholders' Equity 74.36 91.88 107.37 119.30
Total Liabilities and Stockholders' Equity 110.72 137.89 152.19 169.04

Cash Flow Summary (Millions)

Categories 7/31/2017 4/30/2017 1/31/2017 10/31/2016
Net Cash Provided by Operating Activities -24.98 -19.46 -14.10 22.07
Net Cash Provided by Investing Activities 9.43 -7.80 -41.21 7.76
Net Cash Provided by Financing Activities 0.54 -0.29 0.12 53.18

Annual Summary Data (Millions)

Year Sales Net Income EPS
10/20120.00-12.07--
10/20130.00-19.99-4.10
10/20141.00-16.53-0.97
10/20150.00-47.03-1.68
10/20163.99-73.56-2.08
Growth RatesInfinity----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/1710419,72248.03




Report Date : 10/16/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.